Author:
Lister Andrew,Abrey Lauren E.,Sandlund John T.
Abstract
Abstract
Central nervous system involvement with malignant lymphoma whether primary or secondary is an uncommon but not rare complication observed in the management of patients with hematological malignancy. Its importance lies in the considerable morbidity and mortality with which it is associated and the inadequacy of therapy.
In Section I, Dr. Lauren Abrey addresses the totality of the problem of primary central nervous system lymphoma, with emphasis on strategies increasingly dependent on systemic chemotherapy.
In Section II, Dr. John Sandlund reviews the success of sequential clinical trials of overall therapy for acute lymphoblastic leukemia in childhood, identifying those patients at high risk of central nervous system leukemia and the development of a rational therapeutic strategy for prevention.
In Section III, Dr. Andrew Lister discusses the issue of secondary central nervous system involvement with lymphoma and the indications for prophylaxis.
Publisher
American Society of Hematology
Reference97 articles.
1. Bailey P. Intracranial sarcomatous tumors of leptomeningeal origin. Arch Surg. 1929;18:1359–1402.
2. Rosenblum ML, Levy RM, Bredesen SYT, Wara W, Zeigler JL. Primary central nervous system lymphomas in patients with AIDS. Ann Neurol. 1988;23:S13–S16.
3. Welch K, Finkbeiner W, Alpers CE, et al. Autopsy findings in the acquired immune deficiency syndrome. JAMA. 1984;252:1152–1159.
4. Sparano JA, Anand K, Desai J, Mitnick RJ, Kalkut GE, Hanau LH. Effect of highly active antiretroviral therapy on the incidence of HIV-associated malignancies at an urban medical center. J Acquir Immune Defic Syndr. 1999;21:S18–S22.
5. Itoyama T, Sadamori N, Tsutsumi K, et al. Primary central nervous system lymphomas. Cancer. 1994;73:455–463.
Cited by
37 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献